Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 with Concurrent Radiotherapy in Elderly Esophageal Cancer
NCT02716688Phase 2Withdrawn
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in esophageal cancer, sponsored by Zhejiang Provincial People's Hospital. Planned start Jan 2016; status: withdrawn.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02716688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716688.